Article

jdsupra.com on 2017-01-04 20:50

Summary of FDA Clinical Pharmacology Guidance for Demonstrating Biosimilarity

On December 28, 2016, the U.S. Food and Drug Administration (FDA) released a Guidance for Industry, Clinical Pharmacology Data to Support a ...

Related news

FDA Issues New Guidance on Use of Clinical Pharmacology Studies to Show Biosimilarity jdsupra.com
The ABCs of DCTs: New FDA Guidance Provides Recommendations for the Conduct of Decentralized Clinical Trials jdsupra.com
FDA Publishes Informed Consent Final Guidance for Drug and Medical Device Clinical Investigations jdsupra.com
FDA Releases Clinical Cannabis Guidance, Approves Cannabis Product for New Indication jdsupra.com
FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors jdsupra.com
Clinical Trials: FDA Issues Finalized Charging Guidance for Investigational Drug Use jdsupra.com
FDA Issues Final Clinical Decision Support Software Guidance jdsupra.com
Cures
FDA Finalizes Clinical Decision Support (CDS) Software Guidance jdsupra.com
Cures
FDA Releases Guidance on Clinical Research into Cannabis-Derived Drugs jdsupra.com
Clinical Research: FDA Issues Draft Guidance on Informed Consent jdsupra.com
Cures
FDA Issues Final Guidance on “Considerations in Demonstrating Interchangeability With a Reference Product”jdsupra.com
California , United States , Switzerland
From Seed to Study Subject: New Draft Guidance From the FDA and Four Takeaways for Using Cannabis in Clinical Trials jdsupra.com
California
FDA Issues Guidance on Clinical Research for Cannabis Drugs jdsupra.com
FDA Issues Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic jdsupra.com
Rockville , Fishers , United States
FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials jdsupra.com
FDA issues milestone draft guidance on decentralized clinical trial design & implementation jdsupra.com
Digital Health: FDA Issues Long-Awaited Draft Guidance on Clinical Decision Support Technology jdsupra.com
FDA Issues Draft Guidance on Use of Electronic Informed Consent in Clinical Trials jdsupra.com
FDA Issues Draft Guidance Addressing Reliance on Ex-U.S. Clinical Data in Medical Device Premarket Submissions jdsupra.com
United States
FDA Issues Draft Guidance on Digital Health Technologies in Clinical Trials jdsupra.com